Trials / Completed
CompletedNCT02143479
A Multicenter Study in Liver Transplant Patients Converted From Prograf® to Advagraf® During the First Post-transplantation Year
A Cohort Study in Liver Transplant Patients Converted From a Tacrolimus Twice a Day (Prograf®) to Tacrolimus Once a Day (Advagraf®). French, Multisite, Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 398 (actual)
- Sponsor
- Astellas Pharma S.A.S. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A study in which two groups of patients will be analysed; patients converted from Prograf to Advagraf within the first 3 months after transplantation and patients converted from Prograf to Advagraf between 3 months and 1 year after transplantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tacrolimus | oral |
Timeline
- Start date
- 2014-06-18
- Primary completion
- 2017-05-03
- Completion
- 2017-05-03
- First posted
- 2014-05-21
- Last updated
- 2024-10-21
Locations
17 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02143479. Inclusion in this directory is not an endorsement.